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Lowenstein-Jensen Selective Medium for Reducing Contamination in
Mycobacterium tuberculosis Culture
Kennedy Kassaza,a Patrick Orikiriza,a Augusto Llosa,b Joel Bazira,c Dan Nyehangane,a Anne-Laure Page,b Yap Boum IIa,c
Epicentre Mbarara, Mbarara, Ugandaa; Epicentre, Paris, Franceb; Mbarara University of Science and Technology, Mbarara, Ugandac
We comparedMycobacterium tuberculosis sputum culture recovery and contamination rates between Lowenstein-Jensen me-
dium (LJ) containing the following decontaminants and LJ alone: (i) PANTA (n 299), (ii) Selectatab-MB (n 299), and (iii)
penicillin G (n 234). The contamination rate for LJ alone was approximately 31%, versus 5.0% for PANTA-containing, 2% for
Selectatab-containing, and 9% for penicillin-containing media (P< 0.001).M. tuberculosis isolation rates were 9.8%, 17%, 18%,
and 12% for standard LJ, PANTA, Selectatab, and penicillin cultures, respectively.
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is ahigh-burden disease, with over 95% of TB cases occurring in
developing countries (1). Culture remains the gold standard for
detecting TB and drug sensitivity testing (2). However, the effec-
tiveness of culture systems is greatly undermined by contamina-
tion with bacteria and fungi (3). Contamination reduces the pro-
portion of interpretable results, thereby limiting the diagnostic
value of culture systems. Contaminated cultures must be re-
peated, at additional cost to public health systems, which delays or
ultimately prevents TB diagnosis.
Decontamination techniques have been implemented at all
stages of specimen collection and processing. Antimicrobial and
antifungal oral rinse solutions can be used prior to sputum expec-
toration (4), and decontamination using cetrimide, oxalic acid,
and sulfuric acid can be used during sputum processing (5, 6). A
variety of decontaminationmethods have been developed for var-
ious M. tuberculosis culture media. The liquid-culture mycobac-
terium growth indicator tube (MGIT) contains a rapid and sensi-
tive culture medium with low contamination rates. However, its
high cost is prohibitive for resource-limited settings (RLS). The
Bactec 960 liquid culture system uses PANTA (polymyxin B,
amphotericin B, nalidixic acid, trimethoprim, and azlocillin) to
reduce contamination (7). A combination of vancomycin, am-
photericin B, and nalidixic acid (VAN) has also been shown to
minimize contamination in theMiddlebrook 7H11 agar formula-
tion (7).
Although Lowenstein-Jensen medium (LJ) remains the most
common medium used in RLS (8), few studies have assessed the
efficacy of antibiotics on LJ. We assessed the performance of
PANTA (Becton, Dickinson, Franklin Lakes, NJ, USA), mycobac-
terium Selectatab (Selectatab-MB; Mast, Merseyside, United
Kingdom), and penicillin G (Sigma-Aldrich, Gillingham, United
Kingdom) in reducing contamination and improving the yield
and recovery ofM. tuberculosis in LJ.We also characterized a set of
contaminants isolated from antibiotic-free LJ.
Sputum samples were collected as part of routine clinical care
from patients with presumptive TB attending the outpatient de-
partment ofMbarara Regional Referral Hospital (MRRH) and the
Immune Suppressed Syndrome (ISS) (HIV) clinic, Mbarara,
Uganda, betweenOctober 2011 and January 2012. Sputum smears
were prepared for microscopic examination using the auramine-
LED fluorescence technique, and results were reported according
to World Health Organization (WHO) guidelines (9, 10).
All laboratory procedures were performed at the laboratory of
the Epicentre Research Centre in Mbarara, Uganda, which is
monitored by the Institute of TropicalMedicine of Antwerp, Ant-
werp, Belgium. We first processed the sputum for culture using
theN-acetyl-L-cysteine-sodiumhydroxidemethod (11) and inoc-
ulated 200l of sediment into plain LJ or antibiotic-containing LJ
tubes. Two distinct groups of specimens were evaluated by
matched comparison of decontamination techniques. The first
group of 299 sputum specimens was analyzed in triplicate with
plain LJ, LJ with PANTA, and LJ with Selectatab-MB. A second
group of 234 sputum specimenswas analyzed in duplicate to com-
pare plain LJ against LJ containing penicillin G. All media were
prepared according tomanufacturer guidelines. Penicillin-treated
LJ was prepared tomake a final concentration of 100 IU/ml before
coagulating. The costs of PANTA, Selectatab-MB, and penicillin
per test were approximately $0.80, $0.40, and $0.14, respectively.
Tubes were incubated at 37°C for a maximum of 8 weeks. Cul-
tures showing no growth after 8 weeks of incubation were re-
ported as negative. Liquefied or discolored (dark green) LJ media
or LJ slants with colonies of non-acid-fast bacteria were consid-
ered contaminated. Internal quality control formicroscopy and LJ
was performed as previously described (12). For a subset of 20
contaminated LJ tubes, culture liquid was inoculated on blood
agar and incubated at 37°C for 48 h. After growth was detected, an
isolated colony was picked for further characterization using
Gram staining and API Gallery (bioMérieux, Durham,NC, USA).
Data were double entered into Epidata (version 3.1; Epidata
Association, Odense, Denmark) and analyzed using Stata SE ver-
sion 12 software (StataCorp, College Station, TX, USA).We com-
pared contamination rate, yield (proportion of M. tuberculosis
culture-positive specimens among smear-positive specimens),
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and recovery (proportion ofM. tuberculosis culture-positive spec-
imens by sputum smear result) between plain LJ and antibiotic-
containing LJ using McNemar’s test for paired samples.
Contamination rates were 32.1% in plain LJ, 5.0% in LJ-
PANTA, and 2.3% in LJ–Selectatab-MB among 299 matched
specimens (Table 1). While both decontaminant-containing cul-
tures had significantly lower contamination rates than plain LJ
(P  0.001), the difference in rates between the two antibiotic-
containing media was not significantly different (P  0.10).
Among the 234 specimens cultured in both penicillin-treatedme-
dium and plain LJ, contamination rates were 8.9% and 30.7%,
respectively (P 0.001).
TB-positive-culture rates were 11.0% (33/299), 17.4% (52/
299), and 18.4% (55/299) for plain LJ, LJ-PANTA, and LJ–Selec-
tatab-MB, respectively, with a significantly higher proportion in
the decontaminated samples than in plain LJ. In group 2, positive-
culture rates were 12.4% (29/234) and 9.8% (23/234) in penicil-
lin-treated and plain LJ, respectively (P 0.34) (Table 1).
Recovery differed by culture medium type. Among specimens
graded 2/3 (corresponding to more than 10 acid-fast bacilli
per field in at least 50 fields) by microscopy, recovery was 58.8%
(20/34) in plain LJ, 88.2% (30/34)with PANTA (McNemar’s exact
P  0.01), and 97.1% (33/34) with Selectatab-MB (McNemar’s
exact P 0.001) (Table 2). Overall, recovery was 58.7% (27/46) in
plain LJ, which increased to 87% (40/46) with PANTA (McNe-
mar’s exact P 0.001) and to 93.5% (43/46) with Selectatab-MB
(McNemar’s exact P  0.0001). The difference in recovery be-
tween the two treated-medium strategies was not statistically sig-
nificant (McNemar’s exact P 0.25). The recovery rate in LJ with
penicillin was 78.6%.
We evaluated the effectiveness of selected antibiotics in reduc-
ing contamination in LJ. Notably, contamination rates decreased
from approximately 30% with plain LJ to 5% for LJ with the
addition of PANTA or Selectatab-MB (Table 3). Notwithstanding
the improved decontamination rates, positive culture rates in-
creased from 11% to 17 to 18% for the decontaminated media,
and yield increased from 56% to 89 to 97% for specimens that
were graded 2/3 by sputum microscopy. While penicillin G-
containing media also demonstrated lower rates of contamina-
tion, yield and recovery improvements were not seen to the same
degree. Selectatab-MB contains ticarcillin, a penicillin which acts
on Gram-negative bacteria, particularly Pseudomonas aeruginosa.
It is also one of the few antibiotics capable of treating Stenotroph-
omonas maltophilia, one of the major contaminants isolated in
this study, and this is probably why Selectatab-MB performed
better overall. In summary, the addition of PANTA and Select-
atab-MB to standard LJ appears to reduce contamination rates
without reducing the growth or recovery of TB in culture.
Our contamination rates with plain LJ were approximately
31%, greater than the recommended threshold of 5% for labora-
tories that receive freshly collected sputum samples or 5 to 10% for
settings where samples take several days to reach the laboratory
(9). This may be due to enrollment of patients with cough for
more than 2 weeks and no other TB symptoms. Although LJ con-
tains malachite green, which has antibiotic properties, several
other groups have reported similarly high contamination rates
(13). For example, in a recent study carried out at the Zambian
National Reference Laboratory, an LJ contamination rate of
14.9% was reported (14). These data reinforce the need for im-
proved decontamination methods for laboratories that rely on LJ
culture for TB diagnosis and susceptibility testing.
Other strategies to reduce contamination rates have been re-
ported, with varying results. In our setting, we have testedmineral
water rinsing prior to sputum production but with limited ef-
fects (Y. Boum II, unpublished data). A recent study on the use
TABLE 1 General M. tuberculosis yield and contamination ratio in
PANTA-, Selectatab-MB-, and penicillin-treated LJ versus antibiotic-
free LJ
Antibiotic and medium
M. tuberculosis-
positive samples
Contaminated
samples
No. (%) P No. (%) P
PANTA 0.38 0.0001
LJ-PANTA (n 299) 52 (17.4) 15 (5.0)
Plain LJ (n 299) 33 (11.0) 96 (32.0)
Selectatab-MB 0.38 0.0001
LJ–Selectatab-MB (n 299) 55 (18.4) 7 (2.3)
Plain LJ (n 299) 33 (11.0) 96 (32.1)
Penicillin 0.34 0.0001
LJ-penicillin (n 234) 29 (12.4) 21 (8.9)
Plain LJ (n 234) 23 (9.8) 72 (30.8)
TABLE 2 Contamination and Mycobacterium tuberculosis and recovery
according to microscopy grading
Microscopy gradea Antibiotic
No. (%)
Contaminated
cultures
M. tuberculosis-
positive tubes
No AFB (n 253) PANTA 10 (4.0) 12 (4.7)
Selectatab-MB 5 (2.0) 12 (4.7)
None 78 (30.8) 6 (2.4)
Scanty/1 (n 12) PANTA 1 (8.3) 10 (83.3)
Selectatab-MB 1 (8.3) 10 (83.3)
None 4 (33.3) 7 (58.3)
2/3 (n 34) PANTA 4 (11.8) 30 (88.8)
Selectatab-MB 1 (2.9) 33 (97.1)
None 14 (41.2) 20 (58.8)
a Microscopy grading was done according to the WHO/IUATLD scale (1). AFB, acid-
fast bacilli.
TABLE 3 Characterization of contaminants isolated from antibiotic-
free LJ tubes (n 20)
Gram reaction Organism No. (%) detected
Positive Streptococcus spp. 2 (16.7)
Staphylococcus spp. 6 (49.9)
Cellulomonas spp. 2 (16.7)
Fungi 2 (16.7)
Total 12 (60)
Negative Stenotrophomonas spp. 3 (37.5)
Aeromonas spp. 2 (25)
Serratia spp. 1 (12.5)
Brevibacterium spp. 1 (12.5)
Enterobacter spp. 1 (12.5)
Total 8 (40)
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of oral rinse solutions (chlorhexidine and nystatin) showed a
lower contamination rate in samples collected from patients
with presumptive TB, but this was also shown to affect the
recovery of M. tuberculosis (4).
Conclusion. Both Selectatab-MB and PANTA offer excellent
solutions for reducing contamination in LJ. Due to its low cost,
Selectatab-MB should be further explored for use as a medium
additive to improve recovery rates and decrease contamination
for LJ-based culture media in resource-limited settings.
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